메뉴 건너뛰기




Volumn 15, Issue 10, 2014, Pages 1508-1513

Immune and anticancer responses elicited by fully synthetic aberrantly glycosylated MUC1 tripartite vaccines modified by a TLR2 or TLR9 agonist

Author keywords

adjuvants; cancer; carbohydrates; mucins; peptides; vaccines

Indexed keywords

CANCER VACCINE; CPG OLIGODEOXYNUCLEOTIDE; GLYCOPEPTIDE; IMMUNOLOGICAL ADJUVANT; MUCIN 1; TOLL LIKE RECEPTOR 2 AGONIST; TOLL LIKE RECEPTOR 9 AGONIST; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG; RECOMBINANT VACCINE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9;

EID: 84903696056     PISSN: 14394227     EISSN: 14397633     Source Type: Journal    
DOI: 10.1002/cbic.201402077     Document Type: Article
Times cited : (59)

References (52)
  • 24
    • 28244489069 scopus 로고    scopus 로고
    • Angew. Chem. 2005, 117, 7803-7808
    • (2005) Angew. Chem. , vol.117 , pp. 7803-7808


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.